Applied Therapeutics, Inc. — Director's Dealing 2019

May 14, 2019

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Applied Therapeutics Inc. (APLT)
CIK: 0001697532
Period of Report: 2019-05-13

Reporting Person: Funtleyder Leslie D. (Director)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	9171	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Series A Preferred Stock	$		Common Stock (3314)		Direct
Series B Preferred Stock	$		Common Stock (1325)		Direct
Stock Option (right to buy)	$0.04	2026-06-21	Common Stock (18453)		Direct
Stock Option (right to buy)	$4.70	2029-03-06	Common Stock (159502)		Direct

Footnotes

F1: Each share of Series A Preferred Stock and Series B Preferred Stock is convertible at any time at the option of the holder, without payment of additional consideration, into Common Stock, on a one-for-one basis, has no expiration date and is expected to automatically convert into shares of Common Stock upon the closing of the Issuer's initial public offering.

F2: These options became fully vested on April 22, 2019.

F3: One-fourth (1/4th) of the shares subject to the option vested December 26, 2018; one-fourth (1/4th) of the total number of shares vested upon the pricing of the Company's initial public offering; one-fourth (1/4th) of the total number of shares subject to the grant shall vest upon the earlier of (a) the Issuer's stock price reaching a 30% increase over the initial public offering price or (b) March 7, 2022; and one-fourth (1/4th) of the total number of shares March 7, 2020, subject to the Reporting Person continuing to provide service through each such date.